Towa Pharmaceutical Co., Ltd.
TWAPF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $49,576,000 | $35,015,000 | $45,471,000 | $29,252,000 |
| Short-Term Investments | $0 | $17,923,000 | $0 | $0 |
| Receivables | $56,934,000 | $58,758,000 | $61,449,000 | $68,318,000 |
| Inventory | $118,505,000 | $112,708,000 | $108,287,000 | $109,103,000 |
| Other Curr. Assets | $30,969,000 | $28,359,000 | $32,099,000 | $31,102,000 |
| Total Curr. Assets | $255,984,000 | $252,763,000 | $247,306,000 | $237,775,000 |
| Property Plant & Equip (Net) | $170,809,000 | $169,470,000 | $168,423,000 | $165,864,000 |
| Goodwill | $26,234,000 | $27,223,000 | $28,115,000 | $29,306,000 |
| Intangibles | $17,222,000 | $17,292,000 | $17,726,000 | $17,986,000 |
| Long-Term Investments | $6,510 | $862,000 | $3,213,000 | $846,000 |
| Tax Assets | $0 | $0 | $6,037,000 | $0 |
| Other NC Assets | $10,272,490 | $7,621,000 | $0 | $7,227,000 |
| Total NC Assets | $224,544,000 | $222,468,000 | $223,514,000 | $221,229,000 |
| Other Assets | $2,000 | $0 | $3,000 | $0 |
| Total Assets | $480,530,000 | $475,231,000 | $470,823,000 | $459,004,000 |
| Liabilities | – | – | – | – |
| Payables | $16,022,000 | $18,378,000 | $26,990,000 | $19,337,000 |
| Short-Term Debt | $31,202,000 | $29,409,000 | $24,105,000 | $16,720,000 |
| Tax Payable | $4,060,000 | $0 | $4,852,000 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $39,998,000 | $41,864,000 | $31,992,000 | $42,632,000 |
| Total Curr. Liab. | $91,282,000 | $89,651,000 | $87,939,000 | $78,689,000 |
| LT Debt | $205,061,000 | $208,485,000 | $206,878,000 | $206,759,000 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $4,325,000 | $4,375,000 | $4,382,000 | $4,533,000 |
| Total NC Liab. | $209,386,000 | $212,860,000 | $211,260,000 | $211,292,000 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $14,596,000 | $13,396,000 | $13,184,000 | $10,827,000 |
| Total Liabilities | $300,668,000 | $302,511,000 | $299,199,000 | $289,981,000 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $4,717,000 | $4,717,000 | $4,717,000 | $4,717,000 |
| Retained Earnings | $156,747,000 | $151,046,000 | $150,502,000 | $146,140,000 |
| AOCI | $109,106 | $14,702,000 | $14,150,000 | $15,911,000 |
| Other Equity | $18,398,000 | $2,255,000 | $2,255,000 | $2,255,000 |
| Total Equity | $179,862,000 | $172,720,000 | $171,624,000 | $169,023,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $480,530,000 | $475,231,000 | $470,823,000 | $459,004,000 |
| Net Debt | $186,687,000 | $202,879,000 | $185,512,000 | $194,227,000 |